Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mol Biol Rep ; 48(2): 1985-1994, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33619662

RESUMEN

Reck (REversion-inducing Cysteine-rich protein with Kazal motifs) tumor suppressor gene encodes a multifunctional glycoprotein which inhibits the activity of several matrix metalloproteinases (MMPs), and has the ability to modulate the Notch and canonical Wnt pathways. Reck-deficient neuro-progenitor cells undergo precocious differentiation; however, modulation of Reck expression during progression of the neuronal differentiation process is yet to be characterized. In the present study, we demonstrate that Reck expression levels are increased during in vitro neuronal differentiation of PC12 pheochromocytoma cells and P19 murine teratocarcinoma cells and characterize mouse Reck promoter activity during this process. Increased Reck promoter activity was found upon induction of differentiation in PC12 cells, in accordance with its increased mRNA expression levels in mouse in vitro models. Interestingly, Reck overexpression, prior to the beginning of the differentiation protocol, led to diminished efficiency of the neuronal differentiation process. Taken together, our findings suggest that increased Reck expression at early stages of differentiation diminishes the number of neuron-like cells, which are positive for the beta-3 tubulin marker. Our data highlight the importance of Reck expression evaluation to optimize in vitro neuronal differentiation protocols.


Asunto(s)
Proteínas Ligadas a GPI/metabolismo , Genes Supresores de Tumor , Neurogénesis/genética , Teratocarcinoma/metabolismo , Animales , Sitios de Unión , Citometría de Flujo , Proteínas Ligadas a GPI/genética , Regulación Neoplásica de la Expresión Génica/genética , Ratones , Células PC12 , Regiones Promotoras Genéticas , Ratas , Reacción en Cadena en Tiempo Real de la Polimerasa , Teratocarcinoma/genética , Tubulina (Proteína)/metabolismo , Regulación hacia Arriba
2.
An Acad Bras Cienc ; 87(1): 389-404, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25761220

RESUMEN

The altered expression of the SOX2 transcription factor is associated with oncogenic or tumor suppressor functions in human cancers. This factor regulates the migration and invasion of different cancer cells. In this study we investigated the effect of constitutive SOX2 overexpression on the migration and adhesion capacity of embryonal teratocarcinoma NT2/D1 cells derived from a metastasis of a human testicular germ cell tumor. We detected that increased SOX2 expression changed the speed, mode and path of cell migration, but not the adhesion ability of NT2/D1 cells. Additionally, we demonstrated that SOX2 overexpression increased the expression of the tumor suppressor protein p53 and the HDM2 oncogene. Our results contribute to the better understanding of the effect of SOX2 on the behavior of tumor cells originating from a human testicular germ cell tumor. Considering that NT2/D1 cells resemble cancer stem cells in many features, our results could contribute to the elucidation of the role of SOX2 in cancer stem cells behavior and the process of metastasis.


Asunto(s)
Movimiento Celular/fisiología , Factores de Transcripción SOXB1/metabolismo , Teratocarcinoma/metabolismo , Adhesión Celular/fisiología , Línea Celular Tumoral , Proliferación Celular , Regulación Neoplásica de la Expresión Génica , Humanos , Inmunohistoquímica , Masculino , Teratocarcinoma/patología , Análisis de Matrices Tisulares
3.
Braz J Med Biol Res ; 36(1): 29-37, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12532224

RESUMEN

Nascent procollagen peptides and other secretory proteins are transported across the endoplasmic reticulum (ER) membrane through a protein-conducting channel called translocon. Sec61alpha, a multispanning membrane translocon protein, has been implicated as being essential for translocation of polypeptide chains into the cisterns of the ER. Sec61alpha forms a protein complex with collagen and Hsp47, an ER-resident heat shock protein that binds specifically to collagen. However, it is not known whether Sec61alpha is ubiquitously produced in collagen-producing F9 teratocarcinoma cells or under heat shock treatment. Furthermore, the production and utilization of Sec61alpha may depend on the stage of cell differentiation. Cultured F9 teratocarcinoma cells are capable of differentiation in response to low concentrations of retinoic acid. This differentiation results in loss of tumorigenicity. Mouse F9 cells were grown in culture medium at 37 degrees C and 43 degrees C (heat shock treatment) treated or not with retinoic acid, and labeled in certain instances with 35S-methionine. Membrane-bound polysomes of procollagen IV were then isolated. Immunoprecipitation and Western blot analysis were performed using polyclonal antibodies against collagen IV, Hsp47 and Sec61alpha. Under retinoic acid-untreated conditions, F9 cells produced undetectable amounts of Sec61alpha. Sec61alpha, Hsp47 and type IV collagen levels were increased after retinoic acid treatment. Heat shock treatment did not alter Sec61alpha levels, suggesting that Sec61alpha production is probably not affected by heat shock. These data indicate that the enhanced production of Sec61alpha in retinoic acid-induced F9 teratocarcinoma cells parallels the increased synthesis of Hsp47 and collagen type IV.


Asunto(s)
Antineoplásicos/farmacología , Colágeno Tipo IV/metabolismo , Proteínas de Choque Térmico/biosíntesis , Proteínas de la Membrana/biosíntesis , Tretinoina/farmacología , Células Tumorales Cultivadas/efectos de los fármacos , Animales , Western Blotting , Diferenciación Celular/efectos de los fármacos , Colágeno Tipo IV/efectos de los fármacos , Electroforesis en Gel de Poliacrilamida , Proteínas del Choque Térmico HSP47 , Proteínas de Choque Térmico/efectos de los fármacos , Mediciones Luminiscentes , Proteínas de la Membrana/efectos de los fármacos , Ratones , Canales de Translocación SEC , Teratocarcinoma/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA